2010
DOI: 10.1124/jpet.110.175182
|View full text |Cite
|
Sign up to set email alerts
|

Protease-Activated Receptor-1 Antagonist F 16618 Reduces Arterial Restenosis by Down-Regulation of Tumor Necrosis Factor α and Matrix Metalloproteinase 7 Expression, Migration, and Proliferation of Vascular Smooth Muscle Cells

Abstract: Wound healing after angioplasty or stenting is associated with increased production of thrombin and the activation of protease-activated receptor 1 (PAR1). The aim of the present study was to examine the effects of a new selective PAR1 antagonist, 2-[5-oxo-5-(4-pyridin-2-ylpiperazin-1-yl)-penta-1,3-dienyl

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
31
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(32 citation statements)
references
References 36 publications
1
31
0
Order By: Relevance
“…Although the direct relationship between MMP-1 and PAR1 in the atherosclerotic plaque has not yet been shown, genetic deletion of PAR1 or inhibition regulates neointimal hyperplasia after vessel damage in animal models. [70][71][72] Furthermore, as tissue factor may also be increased in atherosclerotic lesions, the contributions of thrombin-PAR1 versus MMP-PAR1 signaling in this context have not been examined. Future studies should be aimed at determining the functional agonist in these settings and whether direct inhibition of the protease would have any beneficial effect.…”
Section: Mmp1-par1 In Platelet Activation and Atherothrombosismentioning
confidence: 99%
“…Although the direct relationship between MMP-1 and PAR1 in the atherosclerotic plaque has not yet been shown, genetic deletion of PAR1 or inhibition regulates neointimal hyperplasia after vessel damage in animal models. [70][71][72] Furthermore, as tissue factor may also be increased in atherosclerotic lesions, the contributions of thrombin-PAR1 versus MMP-PAR1 signaling in this context have not been examined. Future studies should be aimed at determining the functional agonist in these settings and whether direct inhibition of the protease would have any beneficial effect.…”
Section: Mmp1-par1 In Platelet Activation and Atherothrombosismentioning
confidence: 99%
“…Human UCB-MSCs were seeded at 4 · 10 4 cells on low 35-mm dishes with both silicone reservoirs, which are separated by a 500-mm thick wall (Ibidi, Martinsried, Germany) [21] and incubated until the cell reached around 100% confluence in serum-containing medium. After serum starvation for 24 h, the silicone reservoirs were removed with sterile forceps to create a wound field.…”
Section: Wound-healing Migration Assaymentioning
confidence: 99%
“…Human UCB-MSCs were seeded at 4 × 10 4 cells in both silicone reservoirs, which were separated by a 500 μm thick wall (Ibidi, Martinsried, Germany) (Chieng-Yane et al, 2011) and incubated until the cell reached around 100% confluence in the serum-containing medium. After incubation in serumfree medium (serum starvation) for 24 h, the silicone reservoirs were removed with sterile forceps to create a wound field.…”
Section: In Vitro Wound-healing Assaymentioning
confidence: 99%